Michael J. Nowicki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael J. Nowicki has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Phyllis Bishop
University of Mississippi Medical Center, Jackson, MS, USA
5 shared publicationsHua Liu
University of Mississippi Medical Center, Jackson, MS, USA
4 shared publicationsAprile Gilmore
Division of Pediatric Gastroenterology, Blair E. Batson Hospital for Children, University of Mississippi Medical Center, Jackson, Mississippi 39216, USA
1 shared publicationBrandy Hood
University of Mississippi Medical Center, Jackson, MS, USA
1 shared publicationCharu Subramony
Pathology
1 shared publicationDongping Shi
Divisions of Pediatric Gastroenterology, University of Mississippi Medical Center, Jackson, U.S.A.
1 shared publication
Latest Publications
- 16 May 2011
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 50 (10) , 910-915
Juvenile Polyps and Juvenile Polyp Syndromes in Children
In children, most colonic polyps are juvenile polyps with negligible risk for malignant transformation. The exception is juvenile polyposis syndrome (JPS) where there is a risk for developing colon cancer. The authors studied differences in clinical features and colonoscopic findings in children with solitary juvenile polyps (SJP), multiple juvenile polyps (MJP), and JPS. Methods. Children were identified as SJP (1 polyp), MJP (2-4 polyps), or JPS (>5 polyps). Demographic data, laboratory values, family history, and colonoscopic findings were recorded. Results. Children having polypectomy had juvenile polyps (93%), adenomatous polyps (5%), and Peutz–Jegher syndrome (3%). Juvenile polyps were classified as SJP (67%), MJP (16%), and JPS (17%). Children with SJP were younger, were more likely to have polyps limited to the rectosigmoid colon, and had larger polyps than children with MJP and JPS. Anemia was more common in JPS than MJP and SJP. Conclusion. Clinical and endoscopic findings differ between SJP, MJP, and JPS.
- 16 May 2011
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 50 (10) , 910-915
Juvenile Polyps and Juvenile Polyp Syndromes in Children
In children, most colonic polyps are juvenile polyps with negligible risk for malignant transformation. The exception is juvenile polyposis syndrome (JPS) where there is a risk for developing colon cancer. The authors studied differences in clinical features and colonoscopic findings in children with solitary juvenile polyps (SJP), multiple juvenile polyps (MJP), and JPS. Methods. Children were identified as SJP (1 polyp), MJP (2-4 polyps), or JPS (>5 polyps). Demographic data, laboratory values, family history, and colonoscopic findings were recorded. Results. Children having polypectomy had juvenile polyps (93%), adenomatous polyps (5%), and Peutz–Jegher syndrome (3%). Juvenile polyps were classified as SJP (67%), MJP (16%), and JPS (17%). Children with SJP were younger, were more likely to have polyps limited to the rectosigmoid colon, and had larger polyps than children with MJP and JPS. Anemia was more common in JPS than MJP and SJP. Conclusion. Clinical and endoscopic findings differ between SJP, MJP, and JPS.
- 1 November 2010
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 44 (10) , e253-e255
Safety of Blind Percutaneous Liver Biopsy in Obese Children A Retrospective Analysis
Goal To determine the safety and adequacy of blind percutaneous liver biopsy (PLB) in obese children. Background PLB is an important diagnostic tool that, while invasive, enjoys a relatively low major complication rate. An ever increasing reason for pediatric liver biopsy is nonalcoholic fatty liver disease associated with obesity. There is a lack of data assessing the safety of liver biopsy in obese compared to nonobese children. Study A retrospective study of all children over 5 years of age having PLB was conducted. Data collected included age, gender, weight, height, BMI, reason for biopsy, number of passes, biopsy length, number of portal triads per biopsy, and complication rates. Results A total of 107 biopsies were reviewed. All biopsies were successful. Overall, major complications occurred in 1.3% and minor complications in 8.4%; there were no deaths. Comparison revealed no difference for number of passes (1.5±0.7 vs. 1.7±0.7), biopsy length (2.0±1.3 cm vs. 1.5±1.1 cm), number of portal tracts per biopsy (9.8±5.8 vs. 9.9±3.4), or complication rates (major: 0% vs. 1.3%; minor: 10.0% vs. 7.8%) between obese and nonobese children. Conclusion Blind PLB can be safely carried out in obese children with no increase in complication rate compared with nonobese children. Similarly, there is no difference in number of passes, biopsy size, portal triads per biopsy, or biopsy success for obese children.
- 1 November 2010
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 44 (10) , e253-e255
Safety of Blind Percutaneous Liver Biopsy in Obese Children A Retrospective Analysis
Goal To determine the safety and adequacy of blind percutaneous liver biopsy (PLB) in obese children. Background PLB is an important diagnostic tool that, while invasive, enjoys a relatively low major complication rate. An ever increasing reason for pediatric liver biopsy is nonalcoholic fatty liver disease associated with obesity. There is a lack of data assessing the safety of liver biopsy in obese compared to nonobese children. Study A retrospective study of all children over 5 years of age having PLB was conducted. Data collected included age, gender, weight, height, BMI, reason for biopsy, number of passes, biopsy length, number of portal triads per biopsy, and complication rates. Results A total of 107 biopsies were reviewed. All biopsies were successful. Overall, major complications occurred in 1.3% and minor complications in 8.4%; there were no deaths. Comparison revealed no difference for number of passes (1.5±0.7 vs. 1.7±0.7), biopsy length (2.0±1.3 cm vs. 1.5±1.1 cm), number of portal tracts per biopsy (9.8±5.8 vs. 9.9±3.4), or complication rates (major: 0% vs. 1.3%; minor: 10.0% vs. 7.8%) between obese and nonobese children. Conclusion Blind PLB can be safely carried out in obese children with no increase in complication rate compared with nonobese children. Similarly, there is no difference in number of passes, biopsy size, portal triads per biopsy, or biopsy success for obese children.
- 25 January 2010
- Published by Wiley in Pediatrics International
- Vol. 52 (1) , 20-25
Critical analysis of caregiver perceptions regarding gastrostomy tube placement
Gastrostomy tubes (GT) are often required to safely provide nutrition in children with feeding disorders and aspiration risk. The need for a GT brings with it known risks, complications, and benefits, but caregivers may have unspoken concerns and expectations. The present study was done to assess caregiver concerns, expectations, and satisfaction with GT placement in children.A two-part retrospective and prospective study was conducted to assess caregiver concerns and expectations related to GT placement, to determine which concerns and expectations came to fruition, and to rate overall satisfaction with the GT. Questionnaires were used to collect data before and after GT placement. A visual analog scale (VAS) score was used to determine degree of concern and satisfaction.Sixty-four children (19 retrospective, 45 prospective) completed the study. Concern score by VAS was evenly distributed with a mean value of 47.4 +/- 31.8. Concerns were realized in 25%; expectations were met in 93%. Feeding time decreased following GT placement. Satisfaction was reported as satisfied (23.6%), pleased (16.4%), or very pleased (60.0%).Despite pre-placement concerns, most caregivers reported being pleased with the GT following placement. Concerns that occurred were of minor medical significance. Most expectations were met, in particular improved nutrition. The present study provides insight into caregiver concerns and expectations, and which are likely to occur. This information can be useful when counseling caregivers of children requiring GT.
- 25 January 2010
- Published by Wiley in Pediatrics International
- Vol. 52 (1) , 20-25
Critical analysis of caregiver perceptions regarding gastrostomy tube placement
Gastrostomy tubes (GT) are often required to safely provide nutrition in children with feeding disorders and aspiration risk. The need for a GT brings with it known risks, complications, and benefits, but caregivers may have unspoken concerns and expectations. The present study was done to assess caregiver concerns, expectations, and satisfaction with GT placement in children.A two-part retrospective and prospective study was conducted to assess caregiver concerns and expectations related to GT placement, to determine which concerns and expectations came to fruition, and to rate overall satisfaction with the GT. Questionnaires were used to collect data before and after GT placement. A visual analog scale (VAS) score was used to determine degree of concern and satisfaction.Sixty-four children (19 retrospective, 45 prospective) completed the study. Concern score by VAS was evenly distributed with a mean value of 47.4 +/- 31.8. Concerns were realized in 25%; expectations were met in 93%. Feeding time decreased following GT placement. Satisfaction was reported as satisfied (23.6%), pleased (16.4%), or very pleased (60.0%).Despite pre-placement concerns, most caregivers reported being pleased with the GT following placement. Concerns that occurred were of minor medical significance. Most expectations were met, in particular improved nutrition. The present study provides insight into caregiver concerns and expectations, and which are likely to occur. This information can be useful when counseling caregivers of children requiring GT.
- 1 May 2009
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 31 (5) , 309-312
Hepatic Iron Overload in Children With Sickle Cell Anemia on Chronic Transfusion Therapy
Hepatic iron overload is a serious complication of chronic transfusion therapy in patients with sickle cell disease (SCD). No firm consensus has been reached with regard to correlation between hepatic iron content (HIC) and variables including age, number of transfusions, and serum iron makers. Also, the role of HIC in determining hepatic injury is not well established. There is scarcity of data on chronically transfused children with SCD and no other confounding liver pathology. We aimed to further explore relationships between these variables in a cohort of children with SCD on chronic transfusion therapy naive to chelation. Liver biopsies obtained before starting chelation therapy from 27 children with sickle cell anemia receiving chronic transfusion therapy were evaluated for histologic scoring and determination of HIC. Average serum ferritin and iron saturation values were determined for 6 months before biopsy. Duration and total volume of transfusion were obtained from the medical records. All children were negative for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections. Mean age at biopsy was 10.95±3.34 years. Mean duration and total volume of transfusions were 50.0±26.6 months and 17.4±9.6 L, respectively. Pearson product-moment bivariate correlation coefficients indicated significant correlations between HIC and histologic iron score, serum ferritin, iron saturation, age, and transfusion volume. After adjusting for transfusion volume, a significant correlation was only seen between HIC and transfusion volume. Mean HIC was 21.8±10.4 mg/g dry weight, with fibrosis observed in 10 patients and lobular inflammation in 9. HIC was higher in biopsies with fibrosis (28.2±3.8 mg/g) than biopsies without fibrosis (17.6±18.3 mg/g; P=0.012). HIC did not differ between biopsies with lobular inflammation (25.5±4.0 mg/g) and biopsies without inflammation (19.9±2.5 mg/g; P=0.22). These findings show that transfusion volume provides more insight on hepatic iron overload than serum iron markers.
- 1 May 2009
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 31 (5) , 309-312
Hepatic Iron Overload in Children With Sickle Cell Anemia on Chronic Transfusion Therapy
Hepatic iron overload is a serious complication of chronic transfusion therapy in patients with sickle cell disease (SCD). No firm consensus has been reached with regard to correlation between hepatic iron content (HIC) and variables including age, number of transfusions, and serum iron makers. Also, the role of HIC in determining hepatic injury is not well established. There is scarcity of data on chronically transfused children with SCD and no other confounding liver pathology. We aimed to further explore relationships between these variables in a cohort of children with SCD on chronic transfusion therapy naive to chelation. Liver biopsies obtained before starting chelation therapy from 27 children with sickle cell anemia receiving chronic transfusion therapy were evaluated for histologic scoring and determination of HIC. Average serum ferritin and iron saturation values were determined for 6 months before biopsy. Duration and total volume of transfusion were obtained from the medical records. All children were negative for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections. Mean age at biopsy was 10.95±3.34 years. Mean duration and total volume of transfusions were 50.0±26.6 months and 17.4±9.6 L, respectively. Pearson product-moment bivariate correlation coefficients indicated significant correlations between HIC and histologic iron score, serum ferritin, iron saturation, age, and transfusion volume. After adjusting for transfusion volume, a significant correlation was only seen between HIC and transfusion volume. Mean HIC was 21.8±10.4 mg/g dry weight, with fibrosis observed in 10 patients and lobular inflammation in 9. HIC was higher in biopsies with fibrosis (28.2±3.8 mg/g) than biopsies without fibrosis (17.6±18.3 mg/g; P=0.012). HIC did not differ between biopsies with lobular inflammation (25.5±4.0 mg/g) and biopsies without inflammation (19.9±2.5 mg/g; P=0.22). These findings show that transfusion volume provides more insight on hepatic iron overload than serum iron markers.
- 12 November 2008
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 146A (23) , 3090-3091
Hyperamylasemia/hyperlipasemia in a child with propionic acidemia
- 12 November 2008
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 146A (23) , 3090-3091
Hyperamylasemia/hyperlipasemia in a child with propionic acidemia
- 1 February 2004
- Published by Elsevier in Journal of Hepatology
- Vol. 40 (2) , 353
Erythropoietic protophyria in an adolescent female.
- 1 February 2004
- Published by Elsevier in Journal of Hepatology
- Vol. 40 (2) , 353
Erythropoietic protophyria in an adolescent female.
- 1 November 2003
- Published by Springer Nature in Pediatric Research
- Vol. 54 (5) , 732-738
Developmental Expression of Endothelial Nitric Oxide Synthase (eNOS) in the Rat Liver
- 1 November 2003
- Published by Springer Nature in Pediatric Research
- Vol. 54 (5) , 732-738
Developmental Expression of Endothelial Nitric Oxide Synthase (eNOS) in the Rat Liver